Navigation Links
California's Historic RN-to-Patient Hospital Staffing Ratios Upgraded Again With New Year
Date:1/3/2008

ce with the ratio law praise its effects, and nurses in other states cite the importance of winning it elsewhere.

"Finally we have the time to do proper nursing care and fully evaluate each patient's needs." Kathy Dennis, RN, Mercy General Hospital, Sacramento, Ca. "We now have the time to check each patient's chart and make sure there are no treatment delays. And finally there is the time to do the patient and family teaching that is essential to avoiding future complications and hospitalizations."

"Before the ratios were enacted, we had complete turnover of our entire RN staff twice in three years," said Trande Phillips, RN, Kaiser Permanente, Walnut Creek, Ca. "We were always working short staffed and patients suffered. Now the only time nurses leave is if they are moving or going back to school."

"To have it mandated is just the safest way because then (the hospitals) have no choice," said Lynn Rox, RN, Valley Baptist-Harlingen, Brownsville, Tx. "I know of nurses who have left because of the ratios, and if that changed, they would run back to the hospital."

"It is not uncommon for an RN to be responsible for 12 patients on a Med-Surg floor and 1:3 has become the norm for ICU with an occasional 1:4," said Mary Tatum, RN, VA Hospital, Cleveland, Oh. "Minimum staffing levels are essential for quality care."


'/>"/>
SOURCE California Nurses Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Historic Abortion Case; Acuna V. Turkish
2. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
3. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
4. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
5. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
6. Asbestos No More: Historic Asbestos Ban Passage Imminent
7. A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban
8. NDPA Urges Passage of Historic Pool Bill
9. Historic Agreement Reached to More Expertly and Efficiently Expand Proton Therapy Worldwide
10. Historic Global Vigil for AIDS Orphans Ends in New York City
11. New research explores newborn in-hospital weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...g their appointments with their doctors and practi...ted by Developing //Patient Partnerships. The poll...he doctors were not kept while 5 million practice ...ast year. The problem is more prevalent in London ...
...sue of the Journal, Vascular Surgery, researchers ...ve found //that certain risks factors put people y...l vascular disease (PVD). The findings were based...ple younger than 60 and a similar number of people...
...dical Center scientists have discovered that alter...d clues to the reasons why// certain people are vu...TA2 and the army of genes it manipulates may actua...rtery disease. This finding may also show the way ...
...erved that public health and prevention often get ...funding. This is probably// because the significan... saved through expensive, high-tech medical care i...urces could help several more people through preve...
Other Medicine News:Health News:Gene variants hold clues about vulnerability to cardiovascular disease 2Health News:Gene variants hold clues about vulnerability to cardiovascular disease 3Health News:Gene variants hold clues about vulnerability to cardiovascular disease 4Health News:Lives Saved through Simple Changes 2
(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...
(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...
(Date:10/8/2008)...ical improvement in patients with pulmonary a...t options have limited benefit for this debilitati...essel disease, -- Imatinib mesylate, available ...s, known to inhibit protein associated with PAH, ...inib mesylate in PAH in 2009 EAST HANOVER, N...
(Date:10/7/2008)... device for detecting polyps that can be ...Fla., Oct. 7 /- At the American Colle...n Orlando (ACG 2008), renowned,gastroenterologist ...institutional clinical study that evaluated the ef...vice that is designed to improve the ability,of ph...
Breaking Medicine Technology:Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Handbook helps parents deal with childhood infections 1024 1Handbook helps parents deal with childhood infections 1024 2Speed plays crucial role in breaking proteins H bonds 1022 1Speed plays crucial role in breaking proteins H bonds 1022 2Speed plays crucial role in breaking proteins H bonds 1022 3Fuel cells gearing up to power auto industry 1020 1Fuel cells gearing up to power auto industry 1020 2Fuel cells gearing up to power auto industry 1020 3Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 4974 1Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 4974 2
...eady being treated with maximally,tolerated lipid-...ons in LDL-C with similar reductions in other athe... NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007...nc. announced,results from its ongoing Phase 2 cli...gous familial hypercholesterolemia (HoFH),present...
... 2007 /PRNewswire-FirstCall/ --,Alfacell Corporati...nstrating the potential of ONCONASE (ranpirnase) f...CLC) were recently,published in Anticancer Researc...ae Lee, Ph.D., at the University of,Pennsylvania, ...xic,RNase, Ranpirnase, on A549 Human Lung Cancer X...
Other Medicine Technology:Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3
Last 3-6 months average refrigeration will prolong life. Pupil gauge printed on penlight 4 1/2" long 1/2" around.
Maxi-Lite diagnostic penlight features a twist-on backswitch.
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l
Medicine Products: